Development and validation of a 6-plex Luminex-based assay for measuring human serum antibodies to group B streptococcus capsular polysaccharides
Michelle Gaylord(Pfizer (United States)), Peter C. Giardina(Pfizer (United States)), Charles Y. Tan(United States Military Academy), Danka Pavliakova(Pfizer (United States)), Andrew McKeen(Pfizer (United States)), Warren V. Kalina(Pfizer (United States)), Nguyen Hong Ha(Northwestern Medicine), Christopher D. Grube(Pfizer (United States)), Melissa Larrier(Pfizer (United States)), Annaliesa S. Anderson(Pfizer (United States)), Suddham Singh(Pfizer (United States)), Donna Giordano-Schmidt(Pfizer (United States))
Cited by 13
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
|Nature|2020|1.6k
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
|New England Journal of Medicine|2021|937